Posted on

Churriana Integra Race, a festival of sport and integration

Churriana de la Vega hosted the 9th edition of the Churriana Integra Race, a benchmark event in the field of adapted sports in the province of Granada. Of course, Team ROVI Granada could not miss the competition, organised by the Granada Integra Foundation, which had more than 1,000 runners registered

A special route around the Air Base

This year, due to the works that prevented the normal circuit of previous editions, the Churriana Integra Race included in one of its sections the Armilla Air Base, being able to run through an area hitherto unexplored in the event and making this year a special occasion.

A celebration of sport and inclusion

The City Council of Churriana de la Vega and the Granada Integra Foundation wanted to close the event with a solidarity paella for all participants, demonstrating that sport brings people together and motivates us to get the best out of ourselves.

Don’t miss the video of the event!

Posted on

Capital Markets Day 2025

ROVI lays the foundations for its future growth: it forecasts that its contract manufacturing business sales will double by 2030.

  • ROVI forecasts that its 2024 operating revenue will be multiplied by between 1.5 and 1.8 in six years, driven primarily by an increase in its contract manufacturing business sales.
  • The company will reinforce its current position as one of the major global leaders in the fill and finish of injectables after expanding its installed capacity.
  • ROVI expects the specialty pharmaceutical division to grow annually by a low-single-digit percentage in the period from 2024 to 2030, with Okedi® as the primary growth driver.
  • The company plans to commence the next phases of the clinical development of Letrozole SIE and three-monthly risperidone.

You can watch the presentation of the Capital Markets Day ROVI 2025 in this video.